Cargando…

Change in Quality of Life after Medical and Surgical Treatment of Graves’ Ophthalmopathy

PURPOSE: To assess the changes in quality of life (QOL) of patients after treatment of their Graves’ ophthalmopathy (GO). MATERIALS AND METHODS: In this prospective, cross-sectional study, the GO-QOL questionnaire was completed by 67 subjects before and at least 6 months after steroid treatment (61...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kashkouli, Mohsen Bahmani, Heidari, Iraj, Pakdel, Farzad, Jam, Sara, Honarbakhsh, Yasamin, Mirarmandehi, Bahareh
Formato:	Texto
Lenguaje:	English
Publicado:	Medknow Publications 2011
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3085151/ https://www.ncbi.nlm.nih.gov/pubmed/21572733 http://dx.doi.org/10.4103/0974-9233.75884

Ejemplares similares

Quality of Life in Patients with Thyroid Eye Disease
por: Bahmani-Kashkouli, Mohsen, et al.
Publicado: (2009)

Bilateral versus unilateral thyroid eye disease
por: Kashkouli, Mohsen Bahmani, et al.
Publicado: (2011)

Lacrimal Drainage Obstruction Associated with Topical and Systemic Medications
por: Pakdel, Farzad, et al.
Publicado: (2009)

Lacrimal Gland Fistula after Upper Eyelid Blepharoplasty
por: Kashkouli, Mohsen Bahmani, et al.
Publicado: (2011)

Assessment and Management of Proximal and Incomplete Symptomatic Obstruction of the Lacrimal Drainage System
por: Kashkouli, Mohsen Bahmani, et al.
Publicado: (2012)

Update on the medical treatment of Graves’ ophthalmopathy
por: Griepentrog, Gregory J, et al.
Publicado: (2009)

Assessment of Quality of Life and Depression in Korean Patients with Graves' Ophthalmopathy
por: Lee, Hun, et al.
Publicado: (2010)

Autophagy in graves’ ophthalmopathy
por: Chen, Yu-Qing, et al.
Publicado: (2023)

Graves’ Ophthalmopathy in the Setting of Primary Hypothyroidism
por: Alajmi, Sarah, et al.
Publicado: (2022)

Immunological Aspects of Graves' Ophthalmopathy
por: Łacheta, Dominika, et al.
Publicado: (2019)

The Influence of Juvenile Graves' Ophthalmopathy on Graves' Disease Course
por: Jankauskiene, Jurate, et al.
Publicado: (2017)

Development and psychometric properties of the Thai Graves’ ophthalmopathy quality of life (GO-QOL) questionnaire
por: Lumyongsatien, Mingkwan, et al.
Publicado: (2019)

Graves' Ophthalmopathy: A Review of Immunogenetics
por: Khalilzadeh, Omid, et al.
Publicado: (2011)

Radiotherapy in the treatment of Graves ophthalmopathy—to do it or not?
por: Zygulska, Aneta
Publicado: (2009)

Graves’ Ophthalmopathy Misdiagnosed as Relapsing Conjunctivitis
por: Chatziralli, Irini P., et al.
Publicado: (2010)

Imaging Evaluation of the Orbit in Graves Ophthalmopathy
por: SAS, T.N., et al.
Publicado: (2015)

Precision Medicine in Graves’ Disease and Ophthalmopathy
por: Elia, Giusy, et al.
Publicado: (2021)

Orbital endoscopic decompression in Graves Ophthalmopathy
por: Lima, Wilma Terezinha Anselmo, et al.
Publicado: (2015)

ODP533 Graves’ Ophthalmopathy in the Setting of Primary Hypothyroidism
por: Alajmi, Sarah, et al.
Publicado: (2022)

Predictive Factors of Development of Graves' Ophthalmopathy for Patients with Juvenile Graves' Disease
por: Jarusaitiene, Dalia, et al.
Publicado: (2016)

Comparative Evaluation of Oculometric Variables in Graves’ Ophthalmopathy
por: Miot, Hélio Amante, et al.
Publicado: (2009)

Severe Grave's Ophthalmopathy–missed for many years
por: Wani, Mohd Maqbool, et al.
Publicado: (2010)

Thyroid antibody-negative euthyroid Graves’ ophthalmopathy
por: Tabasum, Arshiya, et al.
Publicado: (2016)

The association of carotid cavernous fistula with Graves’ ophthalmopathy
por: Celik, Ozlem, et al.
Publicado: (2013)

The Influence of Prior Hyperthyroidism on Euthyroid Graves' Ophthalmopathy
por: Termote, Karolien, et al.
Publicado: (2014)

The Potential Role of Osteopontin in the Pathogenesis of Graves’ Ophthalmopathy
por: Lou, Heng, et al.
Publicado: (2021)

Cytokines as Targets of Novel Therapies for Graves’ Ophthalmopathy
por: Fallahi, Poupak, et al.
Publicado: (2021)

Tear-derived exosomal biomarkers of Graves’ ophthalmopathy
por: Shi, Ting-Ting, et al.
Publicado: (2022)

Current insights of applying MRI in Graves’ ophthalmopathy
por: Song, Cheng, et al.
Publicado: (2022)

Related quality of life questionnaire specific to dysthyroid ophthalmopathy evaluated in a population of patients with Graves’ disease
por: Delfino, Laura Carolina, et al.
Publicado: (2017)

Corticosteroid Pulse Therapy for Graves' Ophthalmopathy Reduces the Relapse Rate of Graves' Hyperthyroidism
por: Le Moli, Rosario, et al.
Publicado: (2020)

Association of variant on the promoter of cluster of differentiation 74 in graves disease and graves ophthalmopathy
por: Liu, Yu-Huei, et al.
Publicado: (2020)

Balancing orbital volume reduction and redistribution for a tailored surgical treatment in Graves’ ophthalmopathy
por: Costan, Victor Vlad, et al.
Publicado: (2020)

Recent advances in graves ophthalmopathy medical therapy: a comprehensive literature review
por: Li, Xueting, et al.
Publicado: (2022)

The Evolving Role of Selenium in the Treatment of Graves' Disease and Ophthalmopathy
por: Duntas, Leonidas H.
Publicado: (2012)

Increased serum VEGF and b-FGF in Graves’ ophthalmopathy
por: Ye, Xiaozhen, et al.
Publicado: (2014)

Adiponectin concentration in the orbital fat of patients with Graves’ ophthalmopathy
por: Soiberman, Uri, et al.
Publicado: (2013)

The relationship between Graves’ ophthalmopathy and dry eye syndrome
por: Selter, Jessica H, et al.
Publicado: (2014)

Corticosteroids for Graves' Ophthalmopathy: Systematic Review and Meta-Analysis
por: Tu, Xiaofang, et al.
Publicado: (2018)

Serum Cystatin C Concentrations in Patients with Graves’ Ophthalmopathy
por: Can, Nagehan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ris2sh9dqdrbi7qkq31t9ci701